VN Research & Consulting
 Like us on facebook  Follow us on twitter  Follow us on LinkedIn  IndiaNotes on Google Plus  IndiaNotes on Pinterest  IndiaNotes on Stumbleupon  Subscribe to our feeds

Stocks  A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
You are here : IndiaNotes >> Research & Analysis >> Companies >> Sun Pharmaceutical Industries Ltd. >> Research

Sun Pharma: US business to Drive Growth; Buy

Way2wealth | 08 Feb, 2018  | Follow Author | Add to my Favourites 
  • Rate this article
    (Average Rating 3.5 Based on 2 ratings)

Sun Pharma is one of the world’s largest specialty generic pharmaceutical company. It is India’s top pharmaceutical company. Its global presence is supported by 42 manufacturing facilities spread across six continents, research and development (R&D) centres across the world and a multi-cultural workforce comprising over 50 nationalities. In India, the Company enjoys leadership across 11 different classes of  doctors with 30 brands featuring among top 300 pharmaceutical brands. Sun Pharma’s global footprint covers the U.S., emerging markets, Western Europe, Japan, Canada, Israel, Australia and New Zealand. Its Global Consumer Healthcare (GCH) business is ranked among the Top 10 across four global markets. Its API business footprint is strengthened through 14 world-class API manufacturing facilities around the world.At its CMP on 549, the stock trades at 37.5x its FY2018 Bloomberg earnings estimate of Rs 14.65 EPS.

We believe Sun Pharma is trading at decent valuation and narrow going forward will see new approvals will drive earnings and margins sustainability and hence we are POSITIVE on the stock.

  Read full report Click here to read the full report

524.75 -34.65
525.75 -33.75
Read More
About Way2wealth

Way2Wealth today has established itself as one of India’s ‘Premier Investments Consultancy Firms’, known for making investing simpler, more understandable and profitable for the investors. They offer a wide range of products & services viz: Equity, Derivatives, Currency Futures, Commodities Trading, IPO's, Mutual Funds, Portfolio Management Services & Depository Services.


For more information please write in to [email protected]

Disclaimer: The author has taken due care and caution to compile and analyse the data. The opinions expressed above are only the views of the author, and not a recommendation to buy or sell. Neither the author nor accept any liability whatsoever arising from the use of any of the above contents.

Technical Calls

What are technical calls?

Other Articles

Have a question?